GlassScriptPhysician profile
Sherif Azer
NPI 1730722349
$4,868.52
in general payments reported to CMS, 2019-2025
27 companies · $1,058 in 2025
The $1,058 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $893 · 2022: $1,297 · 2023: $955 · 2024: $666 · 2025: $1,058.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,679.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $615.07 | 2021-2024 | Ozempic, Rybelsus |
| Biohaven Pharmaceutical Holding Company LTD. | $561.61 | 2022 | |
| Madrigal Pharmaceuticals | $540.32 | 2024-2025 | Rezdiffra |
| Astrazeneca Pharmaceuticals LP | $489.85 | 2022-2024 | Breztri, Lokelma |
| Amgen INC. | $349.98 | 2023-2025 | Repatha, Repatha, Evenity |
| Corcept Therapeutics | $268.31 | 2025 | Korlym |
| Biohaven Pharmaceuticals, INC. | $267.75 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $256.77 | 2021-2022 | |
| Glaxosmithkline, LLC. | $249.61 | 2022-2023 | |
| Abiomed | $161.64 | 2023 | Impella |
| Abbott Laboratories | $158.42 | 2024 | Freestyle Libre 3 |
| Inari Medical, INC. | $132.50 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $125.73 | 2025 | Indigo System |
| Gilead Sciences, INC. | $124.98 | 2023 | Epclusa |
| Mannkind Corporation | $119.60 | 2023 | Afrezza |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $113.39 | 2024 | Lifevest |
| Abbvie INC. | $59.07 | 2021 | |
| Biogen, INC. | $52.02 | 2021 | |
| Scilex Pharmaceuticals INC. | $36.45 | 2021 | |
| Exact Sciences Corporation | $34.14 | 2023 | Cologuard Collection Kit |
| Sunovion Pharmaceuticals INC. | $27.84 | 2021 | |
| Sk Life Science, INC. | $25.00 | 2021 | |
| Amneal Pharmaceuticals LLC | $24.98 | 2021 | |
| Harmony Biosciences LLC | $24.88 | 2021 | |
| Dexcom, INC. | $23.85 | 2025 | Dexcom G6 Transmitter |
| Genzyme Corporation | $13.66 | 2021 | |
| Horizon Therapeutics Plc | $11.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherif Azer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.